Dextro-transposition of the great arteries follow up

Dextro-transposition of the great arteries Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating dextro-transposition of the great arteries from other Diseases
Epidemiology and Demographics
Screening
Pre-natal dextro-transposition of the great arteries
Post-natal dextro-transposition of the great arteries
Infants with dextro-transposition of the great arteries
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography or Ultrasound
Cardiac catheterization
Electrophysiology Testing
Treatment
Palliative treatment
Corrective surgery
Follow up
ACC/AHA recommendations for reproduction
Case Studies
Case #1
Dextro-transposition of the great arteries follow up On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dextro-transposition of the great arteries follow up All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dextro-transposition of the great arteries follow up
CDC on Dextro-transposition of the great arteries follow up
Dextro-transposition of the great arteries follow up in the news
Blogs on Dextro-transposition of the great arteries follow up
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Dextro-transposition of the great arteries follow up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

ACC/AHA recommends patients with dextro-Transposition of the Great Arteries to have antibiotics prophylaxis to prevent endocarditis in certain conditions.

(ACC/AHA) recommendations for Endocarditis Prophylaxsis in Dextro-Transposition of the Great Arteries (DONOT EDIT)

“

Recommendations for Endocarditis Prophylaxis Class IIa 1. Antibiotic prophylaxis before dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa is reasonable in those with the following indications: 1. Prosthetic cardiac valve. (Level of Evidence: B) 2. Previous infective endocarditis (IE). (Level of Evidence: B) 3. Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits. (Level of Evidence B) 4. Completely repaired CHD with prosthetic materials, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure. (Level of Evidence: B) 5. Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device that inhibit endothelialization. (Level of Evidence: B) 2. It is reasonable to consider antibiotic prophylaxis against IE before vaginal delivery at the time of membrane rupture in select patients with the highest risk of adverse outcomes. This includes patients with the following indications: 1. Prosthetic cardiac valve or prosthetic material used for cardiac valve repair. (Level of Evidence: C) 2. Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits. (Level of Evidence: C) Class III 1. Prophylaxis against IE is not recommended for nondental procedures (such as esophagogastroduodenoscopy or colonoscopy) in the absence of active infection. (Level of Evidence: C) For ACC/AHA Level of evidence and Classes click:ACC AHA Guidelines Classification Scheme

”